Progression of Pediatric Crohn’s Disease Is Associated With Anti–Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization
Authors:
- 4 October 2023
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 22 (2) , 368-376.e4
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Crohn's and Colitis Foundation of America
- Crohn's & Colitis Foundation
This publication has 24 references indexed in Scilit:
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in ChildrenGastroenterology, 2012
- Epidemiology and Natural History of Inflammatory Bowel DiseasesGastroenterology, 2011
- Definition of Phenotypic Characteristics of Childhood-Onset Inflammatory Bowel DiseaseGastroenterology, 2008
- Natural History of Pediatric Crohn's Disease: A Population-Based Cohort StudyGastroenterology, 2008
- Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in ChildrenGastroenterology, 2007
- The Impact of Increased Body Mass Index on the Clinical Course of Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2006
- Long-Term Evolution of Disease Behavior of Crohn's DiseaseInflammatory Bowel Diseases, 2002
- Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the diseaseGut, 2001
- Crohn's disease: Influence of age at diagnosis on site and clinical type of diseaseGastroenterology, 1996